Employment and Executive Compensation

Corporate / M&A

On April 12, 2021, Grünenthal GmbH announced the acquisition of Mestex AG through the purchase of all of its shares and outstanding options. Mestex AG is a Swiss biotech company that has developed the innovative investigational medicine MTX-071 (resiniferatoxin) for the intra-articular treatment of pain associated with osteoarthritis of the knee. The investigational medicine is currently concluding Phase II of clinical development and is about to enter Phase III.
Homburger advises Grünenthal GmbH on this matter as to all matters of Swiss law. The Homburger team includes partner Andreas Müller (Corporate / M&amp;A; Employment and Executive Compensation), counsel Peter Müller (Tax; Employment and Executive Compensation), associate Mirko Stiefel and junior associate Daniel Bötticher (both Corporate / M&amp;A). Freshfields Bruckhaus Deringer acts as global transaction counsel to Grünenthal GmbH.

Homburger advises Grünenthal on the acquisition of Mestex

Capital Markets

IP / IT

Vectivio

On April 9, 2021, VectivBio Holding AG announced its initial public offering and listing of its shares on Nasdaq (ticker symbol VECT). VectivBio is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe rare conditions for which there is a significant unmet medical need. Through its IPO, at USD 17 per share, VectivBio raises gross proceeds of USD 146.6 m (including greenshoe). At market close on the first day of trading, VectivBio had a market capitalization of USD 824 m.
Homburger advises VectivBio Holding AG in this matter. The Homburger team includes partner Andreas Müller (Capital Markets; Corporate / M&amp;A; Employment and Executive Compensation), lead associate Margrit Marti, associates Angela Oppliger and Kevin Hubacher and junior associate Daniel Bötticher (all Capital Markets; Corporate / M&amp;A), partner Stefan Oesterhelt and associates Joël Gyger and Raphaël Fellay (all Tax), and partner Luca Dal Molin (IP/IT).

Daniel
Bötticher

Homburger advises Grünenthal on the acquisition of Mestex

Homburger advises VectivBio on its IPO on Nasdaq

Join the Team

Daniel Bötticher

Career

Languages

Bar Registration

Teams

DanielBötticher

Homburger advises Grünenthal on the acquisition of Mestex

Homburger advises VectivBio on its IPO on Nasdaq

Join the Team

Daniel Bötticher

Career

Languages

Bar Registration

Teams

Daniel
Bötticher